Skip to content

Veracyte

US · VCYT #2330 by market cap Listed 1970
25.13 +0.09 +0.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 15 in the most recent period (2026/Q3).
  • Total institutional ownership rose 6.0 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
118.51% +6.01pp
Institutions
465 +15
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund107.17%
Public Company4.01%
Hedge Fund3.46%
Government Pension Fund1.91%
Private Company0.74%
Individual/Insider0.59%
Insurance Company0.57%
VC/PE Fund0.34%
Family Office/Trust0.14%
Sovereign Wealth Fund0.12%

Top holders as of 2026-09-30

BlackRock 17.21% · 13.89M sh
FMR 8.07% · 6.51M sh
State Street Global Advisors 6.86% · 5.53M sh
Artisan Partners Limited Partnership 6.89% · 5.54M sh
Vanguard Portfolio Management, LLC 5.99% · 4.84M sh
Vanguard Capital Management, LLC 4.46% · 3.60M sh
ARK Investment Management LLC 3.67% · 2.96M sh
William Blair Investment Management, LLC 3.58% · 2.89M sh
Dimensional Fund Advisors 3.33% · 2.69M sh
First Trust Advisors L.P. 3.11% · 2.51M sh
Wellington Management Group 2.83% · 2.27M sh
GW&K Investment Management, LLC 2.99% · 2.41M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 15 buys · 35 sells

NameRoleStake
Marc Stapley Chief Executive Officer 0.20%
Robert Epstein Independent Chairperson 0.06%
Eliav Barr Director and Member of Scientific & Technology Advisory Board 0.06%
Rebecca Chambers Chief Financial Officer 0.04%
Muna Bhanji Independent Director 0.04%
Evan Jones Independent Director 0.04%
Phillip Febbo Chief Scientific & Medical Officer 0.03%
Jens Holstein Independent Director 0.03%
David Shafer Independent Director 0.02%
Thomas Miller Director and Member of Scientific & Technology Advisory Board 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-27 Jonathan Wygant Vice President Sale to Issuer -1,306 $50.31
2026-10-26 Karin Eastham Independent Director Open Market Disposition -4,850 $50.00
2026-10-26 Karin Eastham Independent Director Intent to Sell (Form 144) -14,850 $48.20
2026-10-26 Karin Eastham Independent Director Derivative Exercise and Sale -10,000 $27.01–50.00
2026-10-26 Jens Holstein Independent Director Derivative Exercise and Sale -15,000 $35.30–50.00
2026-10-26 Jens Holstein Independent Director Intent to Sell (Form 144) -7,500 $50.00
2026-10-18 Muna Bhanji Independent Director Automatic Disposition -1,864 $43.70
2026-09-23 Jens Holstein Independent Director Intent to Sell (Form 144) -7,500 $47.00
2026-09-20 John Leite Global Chief Commercial Officer Automatic Disposition -4,015 $40.00
2026-09-13 Jens Holstein Independent Director Automatic Disposition -5,000 $40.95
2026-09-03 Phillip Febbo Chief Scientific & Medical Officer Open Market Disposition -13,110 $42.89–43.66
2026-09-03 Rebecca Chambers Chief Financial Officer Open Market Disposition -3,652 $42.81–43.71
2026-09-03 Annie McGuire Executive VP, General Counsel & Head of Market Access Open Market Disposition -3,254 $42.79–43.67
2026-09-01 Phillip Febbo Chief Scientific & Medical Officer Sale to Issuer -3,639 $44.88
2026-09-01 Marc Stapley Chief Executive Officer Sale to Issuer -8,782 $44.88
2026-09-01 Jonathan Wygant Vice President Sale to Issuer -1,361 $44.88
2026-09-01 Rebecca Chambers Chief Financial Officer Sale to Issuer -3,603 $44.88
2026-09-01 John Leite Global Chief Commercial Officer Sale to Issuer -3,961 $44.88
2026-09-01 Annie McGuire Executive VP, General Counsel & Head of Market Access Sale to Issuer -3,215 $44.88
2026-08-31 Muna Bhanji Independent Director Automatic Disposition -1,864 $42.97

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Veracyte discussion 0 comments

Add a comment